pol Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy

作者: Eleonor Brandin , Lena Lindborg , Katarina Gyllensten , Christina Broström , Lars Hagberg

DOI: 10.1089/088922203322230905

关键词:

摘要: There is limited knowledge about how to treat and interpret results from genotypic resistance assays in HIV-2 infection. Here, genetic variation pol gene was studied 20 of 23 known cases Sweden. Five patients with signs virological treatment failure were longitudinally studied. Clinical, immunological data collected the protease (PR) first half reverse transcriptase (RT) amplified directly sequenced plasma samples. Moderate extensive evolution observed four five who failed treatment. Some mutations occurred at positions confer HIV-1, but many other PR RT. All had been treated zidovudine alone or combination antiretroviral drugs, none displayed a mutation position 215, which primary site HIV-1. Instead, E219D evolved virus two Q151M patients. A M184V indicative lamivudine detected three The one patient ritonavir, nelfinavir, lopinavir successively acquired nine unusual gene, most are not considered secondary Our indicate that evolutionary pathways lead HIV-1 exhibit both similarities differences. Genotypic cannot be interpreted using algorithms developed for instead new specific have developed.

参考文章(22)
A. J.A.M. van der Ven, A. Riegr, A. Branten, R. Reiman, T. B. Vree, P. P. Koopmans, J. W.M. van der Meer, Cutaneous reactions to trimethoprim-sulphametrole in AIDS patients treated for Pneumocystis carinii pneumonia. AIDS. ,vol. 10, pp. 341- 342 ,(1996) , 10.1097/00002030-199603000-00017
Marchelle I. Allen, Manon Deslauriers, C. Webster Andrews, Graham A. Tipples, Kathie-Anne Walters, David L. Tyrrell, Nathaniel Brown, Lynn D. Condreay, , Identification and characterization of mutations in hepatitis B virus resistant to lamivudine Hepatology. ,vol. 27, pp. 1670- 1677 ,(1998) , 10.1002/HEP.510270628
Marchina E. van der Ende, Martin Schutten, Thoai Duong Ly, Rob A. Gruters, Albert D.M.E. Osterhaus, HIV-2 infection in 12 European residents: virus characteristics and disease progression. AIDS. ,vol. 10, pp. 1649- 1655 ,(1996) , 10.1097/00002030-199612000-00009
THOMAS LEITNER, GALINA KOROVINA, SILVIA MARQUINA, TATYANA SMOLSKAYA, JAN ALBERT, Molecular Epidemiology and MT-2 Cell Tropism of Russian HIV Type 1 Variants AIDS Research and Human Retroviruses. ,vol. 12, pp. 1595- 1603 ,(1996) , 10.1089/AID.1996.12.1595
N.A. Smith, T. Shaw, N. Berry, C. Vella, L. Okorafor, D. Taylor, J. Ainsworth, A. Choudhury, R.S. Daniels, S. El-Gadi, A. Fakoya, G. Moyle, J. Oxford, R. Tedder, S. O'Shea, A.de Ruiter, J. Breuer, Antiretroviral Therapy for HIV-2 Infected Patients Journal of Infection. ,vol. 42, pp. 126- 133 ,(2001) , 10.1053/JINF.2001.0792
Sören Andersson, Hans Norrgren, Zacarias da Silva, Antonio Biague, Sana Bamba, Shirley Kwok, Cindy Christopherson, Gunnel Biberfeld, Jan Albert, Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually Infected Individuals in Guinea-Bissau, West Africa: Significantly Lower Plasma Virus Set Point in HIV-2 Infection Than in HIV-1 Infection JAMA Internal Medicine. ,vol. 160, pp. 3286- 3293 ,(2000) , 10.1001/ARCHINTE.160.21.3286
Vincent Soriano, Perp�tua Gomes, Walid Heneine, Africa Holgu�n, Manuela Doruana, Rute Antunes, Kamal Mansinho, William M. Switzer, Carlos Araujo, Vedapuri Shanmugam, Helena Louren�o, Juan Gonz�lez-Lahoz, Francisco Antunes, Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. Journal of Medical Virology. ,vol. 61, pp. 111- 116 ,(2000) , 10.1002/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W
Marchina E. van der Ende, Christophe Guillon, Patrick H. M. Boers, Thoai Duong Ly, Rob A. Gruters, Albert D. M. E. Osterhaus, Martin Schutten, Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy. Journal of Acquired Immune Deficiency Syndromes. ,vol. 25, pp. 11- 18 ,(2000) , 10.1097/00042560-200009010-00002